Universe Pharmaceuticals Inc (UPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,498 | 5,285 | 5,712 | 8,078 | 10,058 |
| Marketable Securities | N/A | N/A | 13,149 | 13,725 | N/A |
| Receivables | 18,572 | 12,997 | 15,184 | 15,811 | 10,872 |
| Inventories | 1,737 | 3,343 | 2,207 | 2,463 | 1,906 |
| Other current assets | 978 | 3,607 | 3,531 | 2,738 | 444 |
| TOTAL | $51,638 | $25,270 | $41,506 | $50,481 | $23,280 |
| Non-Current Assets | |||||
| PPE Net | 3,568 | 3,700 | 4,251 | 4,681 | 4,428 |
| Investments And Advances | 713 | 685 | 703 | 745 | 735 |
| Intangibles | 263 | 149 | 158 | 179 | 175 |
| Other Non-Current Assets | 11,772 | 11,921 | 12,923 | 14,059 | 187 |
| TOTAL | $16,316 | $16,455 | $18,034 | $19,664 | $5,524 |
| Total Assets | $67,953 | $41,725 | $59,540 | $70,145 | $28,804 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,857 | 5,483 | 3,936 | 4,334 | 2,646 |
| Accounts payable and accrued liabilities | 11,815 | 5,125 | 6,455 | 5,330 | 3,648 |
| Accrued Expenses | 1,620 | 2,712 | 2,539 | 444 | 376 |
| TOTAL | $20,313 | $13,754 | $13,098 | $11,210 | $8,001 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,138 | N/A | N/A | N/A | N/A |
| TOTAL | $2,138 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $22,451 | $13,754 | $13,098 | $11,210 | $8,001 |
| Shareholders' Equity | |||||
| Common Shares | 482 | 68 | 68 | 68 | 50 |
| Retained earnings | -10,172 | -1,444 | 16,322 | 25,059 | 13,739 |
| Other shareholders' equity | 1,327 | 67 | 773 | 4,528 | 3,335 |
| TOTAL | $45,503 | $27,970 | $46,442 | $58,934 | $20,803 |
| Total Liabilities And Equity | $67,953 | $41,725 | $59,540 | $70,145 | $28,804 |